Parkinson's disease is the second most common neurodegenerative disease and is typically characterized by the reduction of dopaminergic neurons partially attributed to mitochondrial alteration, inflammation, and alpha-synuclein aggregation (Pardo-Moreno et al., 2023). Here, SNCA is linked to Parkinson disease.